Position in IQV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$272,440
-$90,469 QoQ
Shares Held
1,410
-33.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#768
of 1,077 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $232,234,639 across 23 Diagnostics & Research names. IQV ranks #19 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
346,489 | $73,438,343 | |
| 2 | MTD |
Mettler Toledo International Inc/
|
51,387 | $65,647,406 | |
| 3 | CSTL |
Castle Biosciences Inc
|
918,668 | $21,910,231 | |
| 4 | FLGT |
Fulgent Genetics, Inc.
|
1,017,913 | $20,887,574 | |
| 5 | MYGN |
Myriad Genetics Inc
|
3,126,973 | $17,855,015 | |
| 6 | QGEN |
Qiagen N.V.
|
233,416 | $9,126,565 | |
| 7 | GH |
Guardant Health, Inc.
|
38,450 | $5,768,653 | |
| 8 | CDNA |
CareDx, Inc.
|
186,391 | $5,312,143 |
All Filings in IQV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $272,440 | 1,410 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $362,909 | 2,128 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,109,918 | 4,924 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,052,837 | 5,543 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,938,489 | 24,992 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $6,057,844 | 34,361 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $9,257,193 | 47,108 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $22,992,251 | 97,026 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,496,572 | 7,078 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $849,710 | 3,360 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $878,087 | 3,795 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $746,666 | 3,795 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,003,822 | 4,466 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $128,482 | 646 | Shares | Defined | 2023-05-11 | |
| 2022-09-30 | $339,637 | 1,875 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,820 | 13 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $3,005 | 13 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $3,667 | 13 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $1,197,460 | 4,999 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $3,111,631 | 12,841 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $28,391 | 147 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $255,496 | 1,426 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $76,450 | 485 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $1,844 | 13 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,402 | 13 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||